The Ocular Surface System
Maintenance and protection of the smooth refractive surface of the cornea is the function of the Ocular Surface System (Fig.  1) . 1 It is defined as the ocular surface, which includes the surface and glandular epithelia of the cornea, conjunctiva, lacrimal gland, accessory lacrimal glands, and meibomian gland, and their apical (tears) and basal (connective tissue) matrices; the eyelashes with their associated glands of Moll and Zeis; those components of the eyelids responsible for the blink; and the nasolacrimal duct. All components of the system are linked functionally by continuity of the epithelia, by innervation, and by the endocrine, vascular, and immune systems. The rationale for the use of the term "Ocular Surface System" is several-fold. First, the primary, synergistic function of the system components is to provide, protect, and maintain a smooth refractive surface on the cornea. Thus, the term Ocular Surface System is linked to its primary function at the ocular surface. Second, all the epithelia at the ocular surface are continuous, with no breaks between regions, and all are derived from the surface ectoderm. The corneal and conjunctival epithelia are continuous, through the ductal epithelium, to the lacrimal glandular epithelium, as is the case with the accessory lacrimal glands, the meibomian gland, and the nasolacrimal system. The glandular systems are essentially involutions from and specializations of the surface epithelium. Communication along these epithelia occurs through gap junctions and cytokines. [2] [3] [4] Third, all regions of the ocular surface epithelia produce components of the refractive tear film; the corneal and conjunctival epithelia produce hydrophilic mucins that hold tears onto the surface of the eye; the lacrimal and accessory lacrimal glands secrete water and a host of protective proteins; the meibomian gland provides the superficial tear lipid layer that prevents tear evaporation. The nasolacrimal epithelial system adsorbs tear components and is believed to, through its cavernous vascular system, control and regulate tear outflow, helping to maintain the appropriate tear level-a fine balance between secretion and outflow. 5 The functions of the various regions of the continuous epithelia and the eyelid blink are integrated by the nervous, endocrine, circulatory, and immune systems and are supported by the connective tissue with its resident cells and blood vessels.
A unit within the ocular surface system has been termed the "Lacrimal Functional Unit." 6 It is composed of the lacrimal glands (both main and accessory), the ocular surface, and the interconnecting innervation. This term emphasizes the interplay between the lacrimal gland, the ocular surface, narrowly defined as the corneal and conjunctival epithelia, and the nervous system. The Ocular Surface System is a broader concept, in that it recognizes contributions to the tear film of all the regions of the ocular surface epithelia, incorporates the lids and nasolacrimal duct, and recognizes the integrative functions of the endocrine, immune, and vascular systems.
Since the functions of all regions of the Ocular Surface System are closely integrated, especially by innervation from the trigeminal nerves, signals from one region of the system influences the blink, goblet cell secretion, lacrimation, and/or lacrimal gland gene expression. For example, a corneal wound induces alteration of the gene expression profile of the lacrimal gland. 7 Similarly, dysfunctions of or injury to one or more components of the Ocular Surface System can lead to systemwide sequelae such as cicatrizing diseases and dry eye-the latter being defined as a multifactorial disease of the tears and ocular surface that results in symptoms of discomfort, visual disturbance, and tear film instability, with potential damage to the ocular surface. 8 For example, meibomian or lacrimal gland disease induces dry eye. 1 Development of treatments for ocular surface disease may be facilitated by consideration of the Ocular Surface System as a whole, rather than by targeting any one component of the system.
Tear Film and Its Interface with the Ocular Surface Epithelium
The smooth refractive tear film is maintained on the cornea and ocular surface by the blinking of the eyelid to replenish the tears over the cornea, through continuous constitutive secretion of tear components by all areas of the ocular surface epithelia, and by specializations on the apical surfaces of the corneal and conjunctival epithelia. Early hypotheses of tear film structure separated the secretions from the lacrimal gland, meibomian gland, and conjunctival goblet cell mucins into three separate, distinct layers within the tear film; the lipid, aqueous, and mucin layers, respectively. While it is clear that the meibomian gland-derived lipid layer is partitioned on the surface of the aqueous layer, more recent data suggest that the aqueous tears are a mixture of lacrimal fluid and mucins, without a distinct mucin layer within the tears (Fig. 2) . 9, 10 The tear-epithelial cell interface is critical for tear film maintenance on the corneal and conjunctival epithelia. As with all wet-surfaced epithelia of the body, including those of the Ocular Surface System and the gastrointestinal, respiratory, and reproductive systems, maintenance of fluids on the cell surface is facilitated through membrane specialization on the apical surface membrane, where it abuts the luminal surface. A hydrophilic, heavily glycosylated glycocalyx is present on these apical surface membranes of the epithelia. Recent data demonstrate that a major component of the glycocalyx is a class of newly described membrane-associated mucins. 10, 11 At the ocular surface, the apical cell membrane adjacent to the tear film interface is thrown into short membrane folds, termed microplicae (Fig. 2) . Membrane-associated mucins emanate from the tips of the microplicae and extend up to 500 nm from the membrane to form the glycocalyx. 10, 12 The Search for the H185 Antigen Yields
Characterization of Mucins of the Ocular Surface
Protective mechanisms of the ocular surface epithelium include the ability to heal quickly and adhere tenaciously to underlying connective tissue, especially since the cornea and ocular surface are exposed to the "outside" world, and since blinking and eye rubbing puts abrasive pressure on the epithelium. Early studies on protective mechanisms of the corneal epithelium by our group focused on corneal epithelial wound healing and anchorage in normal, healing, and disease conditions. [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] Our major contributions in the wound-healing area include development of organ culture models of wounded rodent corneas, 26 demonstration of increases in specific proteins and glycoproteins during epithelial migration, 15, 17, 19, 27 demonstration that an actin "purse string" coordinates epithelial wound closure, 24 and demonstration that leading-edge cells can be selectively transfected. 25 In the epithelial anchorage field, we developed an in vitro system for study of hemidesmosome formation, 13 demonstrated that hemidesmosome formation occurs on sites of basal lamina where type VII collagen anchoring fibrils insert, 18 demonstrated that hemidesmosome formation requires calcium and is calmodulin mediated, 16 showed that diabetes alters epithelial anchorage and epithelia-basement membrane interactions, 20, 23 and discovered that the ␣6␤4 integrin is a hemidesmosome component. 21 To facilitate studies of epithelial anchorage, monoclonal antibodies were developed to use as probes for study of the molecular composition of hemidesmosomes, anchoring structures of basal cells of the corneal epithelium. Serendipitously, during development of these antibodies, an antibody was found that bound to the apical surface of the corneal epithelium of the rat. On isolation of the antigen, it was found to have a mucin-like character. 28 Because of the dearth of information available about the composition of the apical surface of the human cornea and its potential relevance to surface disease, similar methods were used to develop monoclonal antibodies to the human ocular surface. A human-specific antibody, designated H185, was developed that also recognized a mucin-like molecule on the apical cells of corneal and conjunctival epithelia, that had as its epitope a carbohydrate on the mucin and that appeared to be membrane associated. 29 Subsequent studies of the distribution of the H185 mucin on a series of normal and patients with non-Sjögren's dry eye demonstrated that the antibody binding to apical cells of conjunctival epithelium of the dry eye patients was diminished (Fig. 3) . 30 Finding a clinical alteration of the ocular surface in dry eye patients spurred attempts to isolate and clone the molecule recognized by the H185 antibody and, in so doing, changed the direction of the research in our group from wound healing and epithelial anchorage to that of the role of mucins at the ocular surface in health and disease. The security to make such a major shift in research direction was only possible through 10 years of secure funding provided by an NIH/NEI 10-year Merit Award.
Characteristics of Mucins
Mucins are a class of heavily O-glycosylated glycoproteins, the mass of which may reach 80% carbohydrate. As a result of their heavy glycosylation, they have been difficult to characterize, and it is only with the relatively recent application of molecular cloning techniques that mucin genes have been identified. 31, 32 As a result, there has been an explosion of new information characterizing this class, now numbering 19 unique mucin molecules. Much of this interest has been driven by the fact that some mucins are tumor cell markers. 32 By definition, a glycoprotein is a mucin if it has within its protein backbone tandem repeats of amino acids that are rich in serine, threonine, and proline-the serines and threonines providing sites for O-glycosylation of the molecule. Each mucin gene has a unique tandem repeat amino acid sequence and length, and its alleles vary in number of repetitions of the tandem repeat, which lead to polymorphisms within and among individuals. Human mucin genes are designated MUC1, -2, and so on, in order of discovery; mouse homologues are designated Muc1, and so on. Sequencing of mucin genes has led to the identification of two categories of mucins, secreted, and membrane associated (membrane spanning or membrane tethered; for review see Gendler and Spicer, 31 and Hollingsworth and Swanson). 31, 32 Secreted Mucins. Of the seven secreted mucins identified to date, five are the so-called gel-forming mucins (Fig. 4) . The gel-forming mucins are the largest glycoproteins known, with genes of 15.7 to 17 kb and deduced proteins of approximately 600 kDa. 33 Their N and C termini have cysteine-rich domains, which allow for homomultimer formation, in turn resulting in large polymers that produce the viscous mucus associated with gastric and respiratory tract secretions. The gel-forming mucins are secreted by goblet or glandular cells in all wet-surfaced epithelia of the body. They are moved about on epithelial surfaces by various mechanisms, including tracheal cilia movement, peristalsis, or, in the case of the ocular surface, by eyelid movement, to clean the surfaces of particulate matter. Secreted mucins' hydrophilic character, which results from its heavy glycosylation, helps to hold fluids on epithelial surfaces. Two small secreted mucins have been identified, MUC7 and -9 -both of which lack cysteine-rich domains. MUC7 has been shown to have antimicrobial activity.
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Membrane-Associated Mucins. To date, 9 to 10 membrane-associated mucins have been identified. All have a short cytoplasmic tail and a single transmembrane domain, and most have a very large, highly O-glycosylated extracellular domain, which may extend up to 500 nm into the glycocalyx (Fig. 4) . All wet-surfaced epithelia express several of these mucins, usually in a unique repertoire and with unique glycosylation characteristics. 32 Although all probably contribute to the hydrophilic barrier at the epithelial surface, each may have unique functions as well. Recent data suggest that MUC1 and -4 have signaling capabilities through the cytoplasmic tail and extracellular EGF-like domains, respectively. 32, 35 MUC16 has the largest extracellular domain of the membrane-spanning mucins.
Human Ocular Surface Mucins and Their Alterations in Disease
Attempts to clone the H185 antigen (the mucin we found altered in dry eye 30 ) before the mapping of the human genome was a laborious time-consuming process for mucins, since it required isolation and deglycosylation of sufficient mucin to make antibodies to the peptide core to screen a corneal epithelial cDNA library. During these attempts, human corneal, and conjunctival RNA were screened by Northern blot analysis for expression of the mucin genes known at that time, and message for several mucins, including the gel-forming mucin MUC5AC and two membrane-associated mucins, MUC1 and -4, were identified. 36, 37 Sites of expression of the mucin genes in ocular surface epithelia were localized by in situ hybridization techniques, demonstrating that MUC5AC is produced by the conjunctival goblet cell, that MUC1 is expressed all along the corneal and conjunctival epithelia, and that MUC4 is highly expressed in the conjunctiva, with decrease in message in the limbus and further decrease toward the central cornea (Fig. 5) .
Neither of the two membrane-associated mucins, however, was recognized by the H185 antibody. Attempts at cloning H185 failed in part because of the extreme difficulty in obtaining sufficient mucin from even large-scale, expanded primary cultures of corneal epithelium to allow characterization. Attempts to characterize the H185 mucin were then targeted toward isolation of large quantities of the mucin to obtain peptides from immunoprecipitated H185 for subsequent sequencing by conventional or mass spectrometry, followed by cloning from human gene databases. Production of telomerase immortalized corneal and conjunctival cell lines was arranged to obtain larger amounts of mucin-starting material. 38 Again, during the long laborious process to identify H185, additional work on characterizing MUC5AC expression was done.
After in situ hybridization demonstrated that conjunctival goblet cells express MUC5AC, 36 (diagrammed in Fig. 5 ), peptide antibodies were developed to an unglycosylated N terminus region of the molecule for use in semiquantitative Western blot and ELISA analyses to measure the amount of the mucin in tears of normal subjects and patients with drying ocular surface disease. 39 By comparison to that of normal subjects, the amount of MUC5AC protein in tears of patients with Sjögren's dry eye is significantly less. Similarly, there was significantly FIGURE 3. Impression cytology samples from normal subjects and patients with non-Sjögren's dry eye, showing change in localization pattern of binding of an antibody designated H185, which recognizes an O-acetylated sialic acid on the membrane-associated mucin MUC16. On the normal ocular surface, the antibody binds in a patchwork pattern, some cells binding the antibody intensely, others to a lesser degree, similar to the light, medium, and dark cells seen by scanning electron microscopy. In patients with dry eye, apical cell surface binding is lost and goblet cells bind the antibody intensely (see Danjo et al. 30 for details). less MUC5AC message in conjunctival impression cytology samples from the same Sjögren's patients as measured by realtime PCR. 39 These data demonstrated the feasibility of measuring specific mucins within the tear fluid and demonstrated an alteration in amount of mucin with dry eye.
Western blot analysis of MUC5AC from agarose gel electrophoresis demonstrated that the size of MUC5AC in tears is smaller than that found in the goblet cells of the native conjunctival epithelium. 9 The nature and significance of this alteration is unknown. Perhaps the mucin is modified to prevent gel formation, since an opaque viscous gel could scatter light and interfere with light transmission at the ocular surface.
During the attempts to clone the H185 mucin, new mucins were cloned. Their expression by the ocular surface epithelium was tested, and comparisons to the H185 mucin were made. In 2001, after 20 years of attempting to clone the CA125 antigen-also a mucin-like membrane-associated molecule and an ovarian tumor cell marker-Lloyd and Win 40 were successful. CA125 antigen was identified as a membrane-associated mucin and was designated MUC16. Subsequently, by coimmunoprecipitation experiments with several MUC16 antibodies and the H185 antibody, as well as by histochemical colocalization experiments, the ocular surface H185 mucin was identified as MUC16 (Fig. 6) . 41 Recently, the epitope on MUC16 that the H185 antibody recognizes was identified as an O-acetylated sialic acid. 42 Thus ended a 10-year effort to characterize the H185 antigen.
During the quest to identify the H185 mucin, we were able to map the mucin gene expression profile of the ocular surface epithelia. We also demonstrated that there are two sources of mucins at the ocular surface: the conjunctival goblet cells and the apical cells of the stratified conjunctival and corneal epithelia. Jumblatt et al. 43, 44 confirmed the MUC5AC expression pattern, found a small amount of MUC2 expression by a yet to be determined cell type at the ocular surface, and found the small secreted mucin MUC7 to be expressed by the acinar cells of the lacrimal gland. Recently, MUC16 expression was demonstrated in lacrimal gland ductal epithelium, accessory lacrimal glands, and nasolacrimal duct epithelium. 45 Thus, the entire ocular surface epithelium produces mucins, and the tears contain goblet cell mucin, as well as shed mucins produced by the corneal and conjunctival epithelia. 
MUC16: Regulation and Function at the Ocular Surface
After the H185 antigen was identified as MUC16, many questions arose regarding its alteration in dry eye. Is the alteration in H185 distribution on the ocular surface of patients with dry eye a result of decreased expression of MUC16, increased shedding of its extracellular domain or, since the H185 epitope is a carbohydrate, 42 altered glycosylation? Currently, studies are ongoing to determine the mechanism of alteration of MUC16 in dry eye. To begin to answer these questions, methods have been developed to quantify membrane-associated mucin mRNA expression and protein in human conjunctival epithelium by using impression cytology samples and real-time PCR. Methods have also been developed to quantify mucin concentration in tear wash samples.
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Studies of membrane-associated mucin function and regulation (especially MUC16) are also ongoing. Major questions remain: Do membrane-associated mucins each have unique functions? Also, how are the genes regulated at the ocular surface? To answer these questions, immortalized human corneal and conjunctival epithelial cell lines optimized for mucin expression were developed. 38 Several regulators of mucin gene expression have since been identified by using these cell FIGURE 7. Electron micrographs of corneal epithelial surface microplicae. By transmission electron microscopy, MUC16 (A) and H185 (B) are localized by immunogold methods to the microplicae. Similar methods using field emission scanning electron microscopy were used to show that MUC16 is concentrated on the microplicae (C). Image in (D) summarizes a set of experiments 48 in which we demonstrate that the cytoplasmic tail of MUC16 is tethered to the actin cytoskeleton through members of the actin linking family of proteins known as ERMs (ezrin, rodixin moesin, and merlin). For reference, a lower-magnification scanning electron microscopic view of surface microplicae is shown in (E). 47 Interestingly, all three of these agents-serum, corticosteroids, and vitamin A have been used in treatment of dry eye disease (for a review, see Gipson et al. 10 ). The corneal epithelial cell line has also been useful in studies of the specific functions of MUC16. As in native human corneal epithelium, the mucin emanates from the tips of microplicae in differentiated cultured cells (Fig. 7) . Since it is known that actin filaments insert into microplicae and since the cytoplasmic tail of MUC1 has been shown to associate with the actin cytoskeleton, experiments were conducted to determine whether the cytoplasmic tail of MUC16 associates with the actin cytoskeleton. On analysis of the amino acid sequence, a polybasic sequence in the cytoplasmic tail of the mucin was noted. This sequence is known to associate with the N terminus of ERMs (ezrin, radixin, moesin, and merlin), a class of small proteins that link the cytoplasmic tail of membranespanning molecules to the actin cytoskeleton. In pull-down experiments, GST (glutathione S-transferase)-tagged ERM proteins pulled down peptides to the cytoplasmic tail of MUC16. By comparison, the ERMs did not pull down peptides in which the polybasic sequence was substituted. These data indicated that MUC16 is linked to the actin cytoskeleton in the microplicae. 48 To determine functions of MUC16 on corneal epithelial cells, small interfering (si)RNA methods to knock down expression of the mucin were used. Greater adherence of Staphylococcus aureus was observed (data not shown), as was greater rose bengal dye penetrance (Fig. 8) , indicating MUC16's role in barrier formation at the ocular surface. 48 
Animal Studies of Mucin Expression at the Ocular Surface
Many questions regarding mucin biology cannot be easily answered with human samples or human epithelial cell culture. Thus, animal studies were needed.
Homologues for the membrane-associated mucins 1 and 4, and the secreted mucin MUC5AC have been identified in mice and rats, and their presence at the ocular surface has been demonstrated. 49 -51 Several studies of the mucins in mice have provided information on their appearance during development as well as on their regulation. Developmentally, the appearance of membrane-spanning mucins correlates with eyelid opening at day 14 after birth, with goblet cell mucin MUC5AC appearing earlier-7 days after birth-the stage at which goblet cells first appear in the conjunctiva. 52 Vitamin A deficiency is known in humans to cause drying and keratinization of ocular surface epithelium. To determine whether specific mucins are lost in vitamin A deficiency, a rat model was used. The expression of rMuc4 and rMuc5AC was completely lost in rats fed a vitamin A-deficient diet, although, interestingly, Muc1 expression was not affected. 53 These in vivo data correlate with data from studies of the effect of retinoic acid on regulation of MUC expression in human conjunctival epithelial cells in vitro, showing upregulation of MUC4 and -16 with vitamin A and lack of regulation of MUC1. 47 In a mouse model of allergic conjunctivitis, repetitive application of allergens to the ocular surface induced a reduction of goblet cells and decreases in Muc5AC and Muc4 mRNA; however, recovery to naïve levels in both occurred after a 24-to 48-hour period, indicating a rapid recovery of the mucin system. 51 The role that calcium ions play in providing cationic shielding to allow tight packaging of highly glycosylated Muc5AC in goblet cells was analyzed using vitamin D receptor knockout mice. The vitamin D receptor controls mineral ion homeostasis and calcium absorption in the intestine, and hypocalcemia occurs in animals in which the receptor is ablated. 54 Goblet cells in the hypocalcemic mice, compared to controls, had less Muc5AC antibody binding, an altered granule morphology, and less extractable mucin, 55 indicating the importance of calcium ions in mucin storage within goblet cells.
Since dry eye in humans is predominant in postmenopausal women, the roles of estrogen and progesterone in the regulation of mucin gene expression at the ocular surface were investigated in mice. The roles of hormones in regulating ocular surface mucins were determined in ovariectomized mice in which estrogen and/or progesterone were replaced. Estrogen and/or progestin were found to have no effect on regulation of mucins in ocular surface epithelium, whereas the hormones were involved in mucin regulation in reproductive tract epithelia.
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Summary and Acknowledgements
In summary, the search for the identity of a mucin altered in dry eye has led us down a path of discovery that was eventually successful. The studies that were spawned by this search have significantly amplified our understanding of the Ocular Surface System. We have learned about the character of mucins at the ocular surface, how they function, and how they are regulated. Their alterations in dry eye have been documented, and methods to understand the alteration developed.
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